AHG
Akso Health Group
0.691$
-5.5%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +202.9% | +26.7% | +477.4% | +5.7% | -53.6% | -60.6% | +59.9% | -59.6% | +594.1% | +51.4% | -11.8% | |
| – | +421.8% | +186.4% | +492.0% | -40.1% | -46.7% | -42.1% | +68.1% | -59.6% | +594.1% | +38.1% | -3.4% | |
| – | +719.0% | +146.0% | +589.6% | -56.7% | -88.4% | +126.9% | +44.9% | -63.9% | +974.8% | +106.9% | -99.9% | |
| – | +719.0% | +146.0% | +589.6% | -56.7% | -88.4% | +126.9% | +44.9% | -63.9% | +974.8% | +106.9% | -99.9% | |
| – | – | +73.9% | +1,248.8% | +26.1% | -1.9% | -60.3% | +39.0% | -53.9% | +509.7% | -77.1% | -90.1% | |
| – | – | +31.3% | -100.0% | -208,124,300.0% | – | – | – | -78.4% | -88.7% | -0.5% | +5.2% | |
| – | – | – | – | +63.4% | -39.1% | -91.2% | -17.1% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | -99.3% | |
| – | +107.4% | -41.8% | +388.9% | +96.1% | -30.8% | -55.5% | +166.4% | -69.7% | -69.1% | +339.7% | -44.9% | |
| – | +107.4% | -41.8% | +388.9% | +11.4% | -53.5% | +16.6% | +166.4% | -69.7% | -69.1% | +284.3% | -37.0% | |
| – | – | – | – | – | – | +1,250.0% | – | – | -79.4% | -98.0% | +831.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +0.0% | – | – | – | – | – | – | |
| – | +318.2% | +67.7% | +495.8% | -9.7% | -62.0% | -64.1% | -28.9% | -29.0% | +1,485.8% | +43.9% | -9.1% | |
| – | – | +268.8% | +556.9% | -9.7% | -102.0% | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -0.6% | +11.0% | -7.9% | +0.2% | +266.2% | -61.6% | +212.6% | +1,096.6% | +153.5% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.